Novel prostate therapy boosts survival in study; first big win for cancer treatment vaccine

CHICAGO - An experimental treatment added four months to the lives of men with advanced prostate cancer in a study that tested an entirely new approach to fighting the disease, doctors reported Tuesday. Dendreon Corp.'s Provenge vaccine trains the immune system to fight tumours....More